← All companies
Krystal Biotech, Inc.
KRYS - CIK 0001711279
Market cap$9.21 B
Rank#989
SEC filings483
The table below shows Krystal Biotech, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $496.30M | $344.87M | $358.33M | $161.90M | $268.27M | $187.51M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $127.42M | $104.75M | $42.04M | - | - | - |
| Inventory | $40.48M | $26.51M | $6.99M | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.